These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13870067)

  • 21. Thyroid function in diabetic patients under long-term sulfonylurea treatment.
    NIKKILA EA; JAKOBSON T; JOKIPII SG; KARLSSON K
    Acta Endocrinol (Copenh); 1960 Apr; 33():623-9. PubMed ID: 14427195
    [No Abstract]   [Full Text] [Related]  

  • 22. [A contribution to late results of sulfonylurea therapy].
    BIBERGEIL H
    Med Klin; 1961 Oct; 56():1786-91. PubMed ID: 13868940
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus].
    GUTSCHE H
    Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals.
    CERLETTI P; GREGOLIN C
    Clin Chim Acta; 1959 Jul; 4():579-82. PubMed ID: 13808852
    [No Abstract]   [Full Text] [Related]  

  • 25. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 26. [SULFONYLUREA SENSITIVITY: ITS SIGNIFICANCE IN THE THERAPY AND PROGNOSIS OF DIABETES MELLITUS].
    ANDREEV D
    Munch Med Wochenschr; 1964 Dec; 106():2259-62. PubMed ID: 14341467
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination of DBI with a sulfonylurea in diabetic therepy.
    JONCAS F
    Appl Ther; 1962 May; 4():476-9. PubMed ID: 14452210
    [No Abstract]   [Full Text] [Related]  

  • 28. [PROBLEMS OF LATE FAILURE OF ORAL SULFONYLUREA THERAPY OF DIABETES].
    STRAUZENBERG SE; HALLER H; MEYER H
    Schweiz Med Wochenschr; 1965 May; 95():628-36. PubMed ID: 14305109
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of peroral antidiabetics on the blood count].
    SIMKO V
    Cesk Gynekol; 1961 Dec; 15():561-4. PubMed ID: 13913038
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the effects of sulfonylurea derivatives on the course of acute viral hepatitis].
    LASZLO B; BRUCKNER P
    Munch Med Wochenschr; 1962 Feb; 104():226-34. PubMed ID: 14462647
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of sulfonylurea derivatives on the course of acute viral hepatitis].
    LASZLO B; BRUCKNER P
    Orv Hetil; 1961 Jul; 102():1405-10. PubMed ID: 13759341
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE CLINICAL ADJUSTABILITY OF VARIOUS FORMS OF DIABETES IN DELAYED-ACTION INSULIN THERAPY, COMBINED AND EXCLUSIVELY ORAL THERAPY WITH SULFONYLUREA DERIVATIVES AND BIGUANIDES].
    KNICK B; FOLKERT F
    Munch Med Wochenschr; 1965 Jan; 107():83-8. PubMed ID: 14301179
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diabetes therapy using oral antidiabetics].
    Hasslacher C; Wahl P
    Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
    [No Abstract]   [Full Text] [Related]  

  • 34. [New indications for sulfonylureas?].
    LEUTIGER H
    Med Welt; 1962 Aug; 33():1698-1700. PubMed ID: 14464451
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the problem of diabetes mellitus therapy with sulfonilamide preparations].
    MNATSAKANOV Ts; BOSTANDZHIAN OSh
    Ter Arkh; 1961 Apr; 33():74-80. PubMed ID: 13771569
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral antidiabetics of the sulfonylurea group and their problems in therapy].
    Füsgen I; Summa JD
    Z Gerontol; 1980; 13(1):45-51. PubMed ID: 7456613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [POSSIBLE NON-DIABETIC EFFECTS OF SULFONYLUREA].
    BAUER G
    Medico (Eur); 1963; ():117-21. PubMed ID: 14065436
    [No Abstract]   [Full Text] [Related]  

  • 38. [CLINICAL EVALUATION OF TOLCYCLAMIDE, A HYPOGLYCEMIC AGENT WITHOUT DEMONSTRABLE TOXICITY].
    VARGAS L; LIEBERMAN E; DOMENGE L; LOZANO O
    Rev Invest Clin; 1964; 16():449-62. PubMed ID: 14308569
    [No Abstract]   [Full Text] [Related]  

  • 39. [The combination DBI-sulfonylurea derivative for diabetes mellitus].
    JAKOBSON T
    Nord Med; 1962 May; 67():585-9. PubMed ID: 14450955
    [No Abstract]   [Full Text] [Related]  

  • 40. CYCLAMIDE (K-386) TREATMENT OF DIABETES MELLITUS.
    GRINCHENKO TS
    Fed Proc Transl Suppl; 1964; 23():767-8. PubMed ID: 14196927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.